Adam Brufsky to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Adam Brufsky has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.831
-
Prevalence and determinants of end-of-life chemotherapy use in patients with metastatic breast cancer. Breast J. 2017 Nov; 23(6):718-722.
Score: 0.328
-
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence. Sci Rep. 2019 10 16; 9(1):14863.
Score: 0.095
-
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer. Clin Breast Cancer. 2018 12; 18(6):e1239-e1245.
Score: 0.087
-
Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103). J Clin Oncol. 2018 09 01; 36(25):2621-2629.
Score: 0.087
-
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. J Natl Cancer Inst. 2018 02 01; 110(2).
Score: 0.084
-
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). J Clin Oncol. 2017 Aug 10; 35(23):2647-2655.
Score: 0.080
-
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer. Breast Cancer Res Treat. 2017 Aug; 164(3):649-658.
Score: 0.020
-
Symptom incidence, distress, cancer-related distress, and adherence to chemotherapy among African American women with breast cancer. Cancer. 2017 06 01; 123(11):2061-2069.
Score: 0.020
-
Patterns of change in cognitive function with anastrozole therapy. Cancer. 2015 Aug 01; 121(15):2627-36.
Score: 0.017
-
Metastasis and bone loss: advancing treatment and prevention. Cancer Treat Rev. 2010 Dec; 36(8):615-20.
Score: 0.012